ストックスクリーナーアプリを入手
3.00
2.60%
-0.08
アフターアワーズ：
2.91
-0.09
-3.00%
Climb Bio Inc (CLYM) 最新ニュース
Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb or Sink? - Nasdaq
Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb Or Sink? - Barchart
Some Confidence Is Lacking In ABL Bio Inc. (KOSDAQ:298380) As Shares Slide 30% - Simply Wall St
Are Wall Street Analysts Predicting KKR Stock Will Climb or Sink? - MSN
Domino's, Pool Corp. Climb After Buffett's Berkshire Buys Stake - RTTNews
Deep Track Capital, LP Reduces Stake in Climb Bio Inc - GuruFocus.com
Are Business Services Stocks Lagging Climb Global Solutions, Inc. (CLMB) This Year? - Yahoo Finance
Sri Lankan Stocks Climb, Information Technology Leads The Way - Finimize
Climb Bio Inc. Shifts Focus to Immune-Mediated Diseases - TipRanks
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire
iBio Reports Fiscal First Quarter 2025 Financial Results - The Manila Times
Climb Bio Secures FDA Clearance for SLE Drug Trial, Reports $217.9M Cash Position | CLYM Stock News - StockTitan
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board - GlobeNewswire
Climb Bio Appoints Biotech Veteran Douglas Williams as Board Chair, Strengthens Leadership | CLYM Stock News - StockTitan
Sales climb for EcoSynthetix Inc. in Q3 - Pulp & Paper Canada
Climb Bio to Present at Upcoming Investor Conferences - GlobeNewswire
Nasdaq Futures Climb on Upbeat Alphabet Results, U.S. GDP Data and More Big Tech Earnings on Tap - MSN
Humic Acid Market Set to Climb to USD 1.63 Billion by 2030 - openPR
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN
Tevogen Bio (TVGN) Sees Major Stock Surge After Key AI Move - Stocks Telegraph
Interpublic Group Of Cos., Inc. (IPG): Worth A Small Bite At $32.03 - Stocks Register
Why Lamb Weston Stock Was Climbing Today - Yahoo Finance
Big Bank Stocks Climb. 3 Stocks to Consider Adding to Your Portfolio. - Yahoo Finance
Merck & Co’s Clesrovimab Has Beyfortus Hill To Climb In RSV - Citeline News & Insights
Treasury Yields Climb as Strong Data Sow Doubt on Fed Rate Cuts - Yahoo Finance
Mortgage Demand Sees Sharpest Weekly Drop Since April 2020 As Rates Climb Above 6.5% - Yahoo Finance
Korean growth stocks climb after rate cut - 코리아타임스
Vale Achieves Six-Year High in Iron Ore Output, Copper and Nickel Production Also Climb - Yahoo Finance
European Wax Center Continues to Climb in Franchise Times' Top 400 Ranking - Yahoo Finance
US Mortgage Rates Climb to 6.52%, Highest Since Early August - Yahoo Finance
What You Need to Know Ahead of Bio-Techne's Earnings Release - TradingView
Stocks of B. Riley Financial Inc (RILY) are poised to climb above their peers - SETE News
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event - The Manila Times
‘Retirement super pot’ holders pay themselves around £3m each in a year - Yahoo Finance UK
Climb Bio to present kidney disease treatment study By Investing.com - Investing.com Australia
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024 - GlobeNewswire
Climb Bio to present kidney disease treatment study - Investing.com India
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology - The Bakersfield Californian
A stock that deserves closer examination: Climb Bio Inc. (CLYM) - US Post News
Climb Global (CLMB) Surged on Strong Results - Yahoo Finance
Quarterly IPOs Climb Back Above $1bn - Scrip
US 30-Year Mortgage Rate Climbs by Most in More Than a Year - Yahoo Finance
Climb Global (CLMB) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance
FDA Oncology Approvals Accelerate as Global Cancer Rates Set to Climb 77% - Baystreet.ca
Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19 - ForexTV.com
Climb Bio to Present at William Blair’s Upcoming Conference - GlobeNewswire
Climb Bio to Present at William Blair's Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19 - The Manila Times
0.93%
3.55%
大文字化:
|
ボリューム (24 時間):